How PhRMA finally lost: the inside story of the group’s biggest lobbying failure in years
(By Nicholas Florko for ST A T) W ASHINGTON —The drug industry’s storied lobbying group isn’t accustomed to bad news
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
(By Nicholas Florko for ST A T) W ASHINGTON —The drug industry’s storied lobbying group isn’t accustomed to bad news
Read more(By Ike Swetlitz for ST A T) A federal judge has blocked a Trump administration policy that reduces payments to
Read more(By Lev Facher for ST A T) W ASHINGTON — Drug pricing is on the agenda here in 2019. But
Read more(By Nicholas Florko for ST A T) W ASHINGTON — A powerful Senate Democrat is asking Pfizer to explain why
Read more(By Kelly Gooch for Becker’s Hospital Review ) U.S. Sen. Bill Cassidy, R-La., said federal lawmakers on both sides of
Read more(By Liz Whyte for NPR and The Center for Public Integrity) Sen. Cory Booker, D-N.J., says he will introduce federal
Read moreOn Tuesday, Republicans on the House Ways and Means Committee introduced seven bills to roll back Medicare regulations on hospitals.
Read moreThe rule for the 340B drug discount program, which would set price ceilings and monetary penalties, will begin of next
Read more(By Julie Appleby for Kaiser Health News) On his first day in office, as part of his mission to dismantle
Read more(By Emily Rappleye for Becker’s Hospital Review ) The U.S. House of Representatives is expected to vote the week of
Read more